ProciseDx Plans Additional Financing in Q1 2020
The company will use the funds to develop and market near-patient, 2- to 5-minute tests to detect and monitor biomarkers for inflammatory and autoimmune diseases and for metabolic syndromes.
Read More
Search Results for: point-of-care
UK Trial to Evaluate POC Test for Early Detection of Sepsis
To detect emergent sepsis, the study aims to develop a rapid diagnostic based on multiple biomarkers.
Read More
Researchers Aim to Create Point-of-Care Biosensor for Prostate Cancer
The POC test would immediately help prostate cancer patients who have undergone radical prostatectomy but have positive surgical margins.
Read More
From the Editor: Challenge and Response
In a recent study, researchers describe a new rapid assay for Lyme disease that could lead to a practical test for use by healthcare providers.
Read MoreGNA Biosolutions Closes $13.5 Million Financing Round Backed by US and EU Consortium
Series C funding will finance further development and CE marking of the company’s first molecular point-of-care platform based on pulse-controlled amplification technology.
Read More